In agreement with the curtailed immune response, MALT1−/− mice developed severe disease, characterized by severe depression and paralysis and requiring human euthanasia, whereas MALT1+/+ mice developed only mild disease resolving at 11 dpi, characterized by transiently reduced activity. The gene discussed is MALT1; the disease is depressive symptom measurement.